Clinical Evaluation of Direct Composite Veneer Restorations

Sponsor
Hacettepe University (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT05842590
Collaborator
(none)
100
1
1
24
4.2

Study Details

Study Description

Brief Summary

The objective of this research was to evaluate the clinical success of direct composite veneer restorations performed in permanent incisors affected by molar-incisor hypomineralization.

Condition or Disease Intervention/Treatment Phase
  • Other: Composite Veneer Restoration
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Clinical Evaluation of Direct Composite Veneer Restorations Performed in Permanent Incisors Affected by Molar-Incisor Hypomineralization
Actual Study Start Date :
Aug 2, 2022
Anticipated Primary Completion Date :
Aug 1, 2024
Anticipated Study Completion Date :
Aug 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Direct Composite Veneer

This is a single-arm study. Direct composite veneer restoration will be performed to all patients.

Other: Composite Veneer Restoration
This is a single-arm study. Direct composite veneer Restorations will be performed to all patients.

Outcome Measures

Primary Outcome Measures

  1. 1.Change from baseline to 12 months regarding "Anatomic form" [baseline, 3-month, 6-month,12-month]

    alpha: The general contour of the restorations follows the contour bravo: the general contour of the restoration does not follow the contour of the tooth charlie: The restoration has an overhang does

  2. 2.Change from baseline to 12 months regarding "Marginal adaptation" [baseline, 3-month, 6-month,12-month]

    alpha: Explorer does not catch or has one-way catch when drawn across the restoration/tooth interface bravo: explorer falls into crevice drawn across the restoration/tooth interface charlie: Dentin or base is exposed along the margin

  3. 3.Change from baseline to 12 months regarding "Surface roughness" [baseline, 3-month, 6-month,12-month]

    alpha: the surface of the restoration does not have any surface defects bravo: the surface of the restoration has minimal surface defects charlie: the surface of the restoration has severe surface defects

  4. 4.Change from baseline to 12 months regarding "Marginal staining" [baseline, 3-month, 6-month,12-month]

    alpha: there is no discoloration between the restorations and tooth bravo: there is discoloration on less than half of the circumferential margin charlie: there is discoloration on more than half of the circumferential margin

  5. 5.Change from baseline to 12 months regarding "Retention" [baseline, 3-month, 6-month,12-month]

    alpha: intact bravo: chipped/loss of material charlie: complete loss of crown

  6. 6.Change from baseline to 12 months regarding "Incisal wear" [baseline, 3-month, 6-month,12-month]

    alpha: intact bravo: wear of occlusal surface without tooth surface exposure charlie: wear of occlusal surface with tooth surface exposure

Eligibility Criteria

Criteria

Ages Eligible for Study:
8 Years to 14 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Cooperative children diagnosed with MIH according to European Academy of Paediatric Dentistry (EAPD) criteria

  • Maxillary anterior teeth with MIH-caused coloring and opacity areas

  • Fully erupted anterior teeth

Exclusion Criteria:
  • Patients and parents of patients who accept to participate.

  • Patients who are not in cooperation with the procedure.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hacettepe University Ankara Turkey

Sponsors and Collaborators

  • Hacettepe University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Beste Ozgur, Assistant professor, Hacettepe University
ClinicalTrials.gov Identifier:
NCT05842590
Other Study ID Numbers:
  • HUDHF-Veneer
First Posted:
May 6, 2023
Last Update Posted:
May 6, 2023
Last Verified:
May 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 6, 2023